Examining the Role of Frontline BTKi Monotherapy in CLL

Expert perspectives on the use of frontline BTKi (Bruton's tyrosine kinase inhibitors) monotherapy in the treatment of chronic lymphocytic leukemia (CLL).

Recent Videos